246 related articles for article (PubMed ID: 7982288)
1. Blockade by intravenous losartan of AT1 angiotensin II receptors in rat brain, kidney and adrenals demonstrated by in vitro autoradiography.
Zhuo J; Song K; Abdelrahman A; Mendelsohn FA
Clin Exp Pharmacol Physiol; 1994 Jul; 21(7):557-67. PubMed ID: 7982288
[TBL] [Abstract][Full Text] [Related]
2. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
Fabiani ME; Dinh DT; Nassis L; Casley DJ; Johnston CI
Am J Hypertens; 2000 Sep; 13(9):1005-13. PubMed ID: 10981551
[TBL] [Abstract][Full Text] [Related]
3. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
4. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
5. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
Song KF; Zhuo JL; Mendelsohn FA
Br J Pharmacol; 1991 Dec; 104(4):771-2. PubMed ID: 1810594
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II binding sites in the rat fetus: characterization of receptor subtypes and interaction with guanyl nucleotides.
Feuillan PP; Millan MA; Aguilera G
Regul Pept; 1993 Mar; 44(2):159-69. PubMed ID: 8469771
[TBL] [Abstract][Full Text] [Related]
7. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
9. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
[TBL] [Abstract][Full Text] [Related]
10. Renin release induced by losartan (DuP 753), an angiotensin II receptor antagonist.
Pals DT; Couch SJ
Clin Exp Hypertens; 1993 Jan; 15(1):1-13. PubMed ID: 8385523
[TBL] [Abstract][Full Text] [Related]
11. Mapping of angiotensin II receptor subtypes in peripheral tissues of spontaneously hypertensive rats by in vitro autoradiography.
Song K; Kurobe Y; Kanehara H; Wada T; Inada Y; Nishikawa K; Miyazaki M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S17-9. PubMed ID: 9072342
[TBL] [Abstract][Full Text] [Related]
12. Influence of dietary sodium restriction on angiotensin II receptors in rat adrenals.
Lehoux JG; Bird IM; Briere N; Martel D; Ducharme L
Endocrinology; 1997 Dec; 138(12):5238-47. PubMed ID: 9389507
[TBL] [Abstract][Full Text] [Related]
13. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
14. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
Gibson RE; Thorpe HH; Cartwright ME; Frank JD; Schorn TW; Bunting PB; Siegl PK
Am J Physiol; 1991 Sep; 261(3 Pt 2):F512-8. PubMed ID: 1653532
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
[TBL] [Abstract][Full Text] [Related]
18. The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation.
Breault L; Lehoux JG; Gallo-Payet N
J Clin Endocrinol Metab; 1996 Nov; 81(11):3914-22. PubMed ID: 8923838
[TBL] [Abstract][Full Text] [Related]
19. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
